glp-1 medication craving management strategies Frontiers This JAMA Internal Medicine patient

Current evidence suggests that GLP-1 receptor agonists do not appear to cause disproportionate muscle loss compared to equivalent weight loss achieved through other methods, though individual responses may vary

Constipation may respond to increased fiber intake, adequate hydration, and physical activity, with stool softeners or gentle laxatives if needed

HSA/FSA Eligibility: Most Everlywell tests and virtual care visits are eligible for HSA and FSA reimbursement, and some virtual services may also be covered by insurance

GLP-1 also has a cardio protective function and a vascular protective function as well

Hua, Liraglutide inhibited AGEs induced coronary smooth muscle cell phenotypic transition through inhibiting the NF-B signal pathway